SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sunshield Chemicals informs about outcome of board meeting

13 May 2026 Evaluate
Sunshield Chemicals has informed that the Board of Directors of the Company at its meeting held today i.e. on 13th May 2026, approved the Audited financial results for the quarter and year ended 31st March 2026 and Auditors Report issued by CNK & Associates LLP, Statutory Auditor of the Company are enclosed. Pursuant to Regulation 33(3)(d) the Statutory Auditors of the Company have issued Audit Report with 'Unmodified Opinion' on the Audited Financial Results of the Company for the year ended 31st March 2026; Recommended payment of final dividend @ Rs 3 per equity share of the face value of Rs 10 each for the financial year ended 31st March 2026, subject to approval of shareholders at the ensuing 39th Annual General Meeting (AGM); Based on recommendation of the Nomination and Remuneration Committee, the Board of Directors have approved reappointment of Cyrus Poonevala (DIN: 09420865) as an Independent Director for the second term of five years effective from 15th January 2027 subject to approval of the Members at the ensuing AGM. The details in respect of the above re-appointments of Directors, as required under SEBI Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July 2023 are enclosed as Annexure A. The Board Meeting started at 11.30 am and concluded at 12.55 pm.

The above information is a part of company’s filings submitted to BSE.

Sunshield Chemicals Share Price

1203.90 18.75 (1.58%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2793.55
BASF India 3660.50
Tata Chemicals 693.15
Pidilite Inds. 1598.15
Deepak Nitrite 1560.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: